University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma
Official Title

A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma

Description

Participants in this study have been diagnosed with Multiple Myeloma. They previously participated in the main study and are now being asked to be in this substudy. Participants are being asked for additional blood samples. There will be 7 separate draws about a teaspoon size each. These samples will be used to determine the amount of denosumab in the blood.

Start Date
December 14, 2012
End Date
December 14, 2022
Gender Preference
None
Age Group
18 - 99 years
Principal Investigator
Guido Tricot, MD, PhD
Contact Info

Karen Parrott, 319-353-6347

Department
Department or Field of Study
Keywords
cancer ; denosumab ; holstein ; IRB#201206502 ; multiple myeloma ; phase III ; phase three ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.